142 related articles for article (PubMed ID: 36422798)
1. STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration.
Chen J; Huang S; Li H; Li Y; Zeng H; Hu J; Lin Y; Cai H; Deng P; Song T; Guan T; Zeng H; Liu M
Clin Transl Oncol; 2023 Mar; 25(3):662-672. PubMed ID: 36422798
[TBL] [Abstract][Full Text] [Related]
2. Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden.
Li H; Qian Y; Wang X; Pi R; Zhao X; Wei X
Cell Prolif; 2020 Jan; 53(1):e12719. PubMed ID: 31778258
[TBL] [Abstract][Full Text] [Related]
3. A redox-responsive nanosystem to suppress chemoresistant lung cancer through targeting STAT3.
Feng Q; Chen J; Huang J; Li X; Liu X; Xiao C; Zheng X; Chen X; Li J; Gu Z; Luo K; Xiao K; Li W
J Control Release; 2023 Nov; 363():349-360. PubMed ID: 37748583
[TBL] [Abstract][Full Text] [Related]
4. STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells.
Wang Q; Lu B; Zhang Y; Yu J; Guo J; Zhou Q; Lv H; Sun Y
Hum Cell; 2021 Nov; 34(6):1855-1865. PubMed ID: 34370268
[TBL] [Abstract][Full Text] [Related]
5. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.
Bi S; Chen K; Feng L; Fu G; Yang Q; Deng M; Zhao H; Li Z; Yu L; Fang Z; Xu B
Eur J Pharmacol; 2019 Jul; 855():252-261. PubMed ID: 31085238
[TBL] [Abstract][Full Text] [Related]
6. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
7. STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers.
Chang YF; Lim KH; Chiang YW; Sie ZL; Chang J; Ho AS; Cheng CC
BMC Cancer; 2019 Oct; 19(1):959. PubMed ID: 31619200
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor.
Tierney BJ; McCann GA; Naidu S; Rath KS; Saini U; Wanner R; Kuppusamy P; Suarez A; Goodfellow PJ; Cohn DE; Selvendiran K
Gynecol Oncol; 2014 Oct; 135(1):133-41. PubMed ID: 25038288
[TBL] [Abstract][Full Text] [Related]
9. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
[TBL] [Abstract][Full Text] [Related]
10. High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.
Wallbillich JJ; Josyula S; Saini U; Zingarelli RA; Dorayappan KD; Riley MK; Wanner RA; Cohn DE; Selvendiran K
PLoS One; 2017; 12(1):e0170318. PubMed ID: 28114390
[TBL] [Abstract][Full Text] [Related]
11. Ropivacaine inhibits cervical cancer cell growth via suppression of the miR‑96/MEG2/pSTAT3 axis.
Chen X; Liu W; Guo X; Huang S; Song X
Oncol Rep; 2020 May; 43(5):1659-1668. PubMed ID: 32323811
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and activity of BBI608 derivatives targeting on stem cells.
Zhou Q; Peng C; Du F; Zhou L; Shi Y; Du Y; Liu D; Sun W; Zhang M; Chen G
Eur J Med Chem; 2018 May; 151():39-50. PubMed ID: 29604543
[TBL] [Abstract][Full Text] [Related]
13. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
Wu X; Yan Q; Zhang Z; Du G; Wan X
Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
[TBL] [Abstract][Full Text] [Related]
14. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
Li H; Lu Y; Pang Y; Li M; Cheng X; Chen J
Biomed Pharmacother; 2017 Feb; 86():324-333. PubMed ID: 28011380
[TBL] [Abstract][Full Text] [Related]
15. [Hederagenin inhibits proliferation and promotes apoptosis of cervical cancer CaSki cells by blocking STAT3 pathway].
Fang L; Liu M; Cai L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Feb; 35(2):140-145. PubMed ID: 30975278
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.
Yap J; Salamonsen LA; Jobling T; Nicholls PK; Dimitriadis E
Reprod Biol Endocrinol; 2010 Jun; 8():63. PubMed ID: 20553623
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3.
Lay V; Yap J; Sonderegger S; Dimitriadis E
Int J Oncol; 2012 Aug; 41(2):759-64. PubMed ID: 22614117
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3
Sun X; Xu Q; Zeng L; Xie L; Zhao Q; Xu H; Wang X; Jiang N; Fu P; Sang M
Cancer Med; 2020 Nov; 9(22):8685-8700. PubMed ID: 33040485
[TBL] [Abstract][Full Text] [Related]
19. Gammacerane suppresses the growth of human endometrial carcinoma cells via induction of apoptosis, cell cycle arrest, inhibition of cell migration, invasion and STAT3 signaling pathway.
Wang C; Chen S; Yue X
J BUON; 2020; 25(2):723-728. PubMed ID: 32521859
[TBL] [Abstract][Full Text] [Related]
20. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
Guo YQ; Lu P; Duan ZF; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
